Journals
Books
Articles by keyword Рак яичников
Clinical Prospects of Matrix Metalloproteinases and Their Tissue Inhibitors Study in Ovarian Cancer Patients
E.S. Gershtein, N.V. Levkina, I.V. Tereshkina, V.D. Ermilova, N.D. Kushlinskii, Yu.V. Kruk, O.M. Kuznetsova, L.V. Adamyan, K.P. Laktionov
Matrix Metalloproteinases in Ovarian Cancer Patients
E.S. Gershtein, N.V. Levkina, I.V. Tereshkina, V.D. Ermilova, D.N. Kushlinsky, V.B. Nosov, L.V. Adamian, K.P. Laktionov
Epidermal Growth Factor Receptor and its Ligands Content in Ovarian Tumors
I.B. Manukhin, O.A. Sharashenidze, V.D. Ermilova, Yu.V. Kryuk
Research of Epidermal Growth Factor Receptor and its Ligands in Ovarian Tumors
O.A. Sharashenidze, O.I. Kostyleva, I.B. Manukhin, V.D. Ermilova, R.R. Azigova, Yu.V. Kryuk
Angiogenic factors in ovarian cancer
D.N. Kushlinskii, I.V. Tereshkina, K.P. Laktionov, L.V. Adamyan
Prevention of abnormalities of hemostasis and vte in ovarian cancer patients, undergoing chemotherapy
O.V. Somonova, A.V. Madzhuga, A.L. Elizarova, D.N. Kushlinskii, I.I. Matveeva
Ovarian cancer and matrix metalloproteinases
D.N. Kushlinsky, I.V. Tereshkina, N.V. Levkina, Yu.V. Kryuk
Surgical treatment of ovarian cancer (review)

N.A. Ognerubov – Dr.Sc.(Med.), Professor, Head Department of Oncology, 

G.R. Derzhavin Tambov State Medical University 

D.N. Kushlinsky – Ph.D. (Med.), Department of Radiation and Combined Methods of Treatment  of Gynecological Diseases, A.F. Tsyb Medical Radiological Scientific Center – Branch of the Federal 

State Budgetary Institution «National Medical Research Center of Radiology»  of the Ministry of Health of Russia (Obninsk)

A.S. Shevchuk – Ph.D. (Med.), Head Oncology Department of Surgical Methods  of Treatment (Oncogynecology) Federal State Budgetary Institution «N.N. Blokhin National Medical Research Center for Oncology» of the Ministry of Health of Russia (Moscow)

Clinical implication of the programmed cell death-1 protein PD-1 and its ligand PD-L1 in ovarian cancer (review)

E.S. Gershtein – Dr. Sc. (Biol.), Professor, Leading Research Scientist, Clinical Biochemistry Laboratory, 

N.N. Blokhin National Medical Research Center of Oncology (Moscow)

D.N. Kushlinsky – Ph.D. (Med.), Senior Research Scientist, Department of Radiation and Combined Treatment of Gynecological Diseases, Medical Radiological Scientific Center n.a. A.F. Tsyba – Branch of the Federal State

Budgetary Institution «National Medical Center of Radiology» of the Ministry of Health  of Russian Federation (Moscow)

I.V. Tereshkina – Ph.D. (Med.), Clinical Biochemistry Laboratory, N.N. Blokhin National Medical Research  Center of Oncology (Moscow)

D.O. Utkin – Surgeon, Department of Oncogynecology, Moscow City Oncological Hospital № 62» (Moscow)

N.E. Kushlinskii – Dr.Sc. (Med.), Professor, Academician of RAS, Heard of Clinical Biochemistry Laboratory, N.N. Blokhin National Medical Research Center of Oncology (Moscow)

Ovarian cancer: role and location of radiotherapy

N.A. Ognerubov1, D.N. Kushlinskiy2

1 G.R. Derzhavin Tambov State Medical University of the Ministry of Science and Higher Education of the Russian Federation (Tambov, Russia)

2 A.F. Tsyb MRRC – Branch of the Federal State Budgetary Institution «National Medical Research Center of Radiology» of the Ministry of Health of Russia (Moscow, Russia)

Analysis of methylation levels of miRNA genes in tumors and metastases, taking into account the concentrations of VEGF in the blood plasma of patients with ovarian cancer

V.I. Loginov1, I.V. Tereshkina2, D.N. Kushlinsky3, A.A. Alferov4, A.I. Koltunova5, N.A. Arzhanukhina6, D.V. Rogozhin7, E.A. Braga8, O.V. Kovaleva9, N.E. Kushlinskii10

1,4,8,10 Research Institute of General Pathology and Pathophysiology (Moscow, Russia)

2 A.I. Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of Russia
(Moscow, Russia)

3 Institute for advanced training of healthcare professionals of the Ministry of Health of the Khabarovsk Territory (Khabarovsk, Russia)

4–7,9,10 N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia (Moscow, Russia)

Ovarian cancer and B7-H3 and B7-H4 ligands

O.V. Kovaleva1, D.N. Kushlinskiy2, A.N. Gratchev3, E.P. Shapiro4, A.S. Mochalova5, N.Yu. Sokolov6, N.E. Kushlinskii7

1,3,5–7 N.N. Blokhin National Medical Research Center for Oncology
of the Ministry of Health of the Russian Federation (Moscow, Russia)

2,4 Clinical Center of Oncology (Khabarovsk, Russia)

miRNAs in the regulation of the PD-1/PD-L1 immune checkpoint in ovarian cancer

D.O. Utkin1, V.I. Loginov2, D.N. Kushlinsky3, N.Yu. Sokolov4, A.I. Koltunova5, N.A. Arzhanukhina6, D.V. Rogozhin7, J.G. Pajanidi8, E.A. Braga9

1,4–8 Blokhin National Medical Research Center of Oncology,
Ministry of Health of the Russian Federation (Moscow, Russia)

1 Moscow City Oncology Hospital №62 (Moscow, Russia)

2,9 Institute of General Pathology and Pathophysiology (Moscow, Russia)

3 Institute for advanced training of healthcare professionals of the Ministry of Health
of the Khabarovsk Territory (Khabarovsk, Russia)